Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization

REFERENCES

• Rosen ED, Spiegelman BM. 2014. What we talk about when we talk about fat. Cell 156:20–24. https://doi.org/10.1016/j.cell.2013.12.012.
   PubMed Web of Science ®Google Scholar
• Kusminski CM, Bickel PE, Sherer PE. 2016. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discovery 15:639–660. https://doi.org/10.1038/nrd.2016.75.
   PubMed Web of Science ®Google Scholar
• Chawla A, Lazar MA. 1994. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci U S A 91:1786–1790.
   PubMed Web of Science ®Google Scholar
• Tononoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147–1156. https://doi.org/10.1016/0092-8674(94)90006-X.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. 1999. PPAR is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611–617. https://doi.org/10.1016/S1097-2765(00)80211-7.
   PubMed Web of Science ®Google Scholar
• Tamori Y, Masugi J, Nishino N, Kasuga M. 2002. Role of peroxisome proliferator-activated receptor-γ in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51:2045–2055. https://doi.org/10.2337/diabetes.51.7.2045.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK. 1995. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci U S A 92:7921–7925.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM. 1995. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15:351–357.
   PubMed Web of Science ®Google Scholar
• He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM. 2003. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 100:15712–15717. https://doi.org/10.1073/pnas.2536828100.
   PubMed Web of Science ®Google Scholar
• Jones JR, Barrick C, Kim K-A, Lindner J, Blondeau B, Fujimoto Y, Shiota M, Kesterson RA, Kahn BB, Magnuson MA. 2005. Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 102:6207–6212. https://doi.org/10.1073/pnas.0306743102.
   PubMed Web of Science ®Google Scholar
• Wang F, Mullican SE, DiSpirito JR, Peed LC, Lazar MA. 2013. Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARgamma. Proc Natl Acad Sci U S A 110:18656–18661. https://doi.org/10.1073/pnas.1314863110.
   PubMed Web of Science ®Google Scholar
• Imai T, Takakuwa R, Marchand S, Dentz E, Bornert J-M, Messaddeq N, Wendling O, Mark M, Desvergne B, Wahli W, Chambon P, Metzger D. 2004. Peroxisome proliferator-activated receptor γ is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A 101:4543–4547. https://doi.org/10.1073/pnas.0400356101.
   PubMed Web of Science ®Google Scholar
• Metzger D, Imai T, Jiang M, Takukawa R, Desvergne B, Wahli W, Chambon P. 2005. Functional role of RXRs and PPARγ in mature adipocytes. Prostaglandins Leukot Essent Fatty Acids 73:51–58. https://doi.org/10.1016/j.plefa.2005.04.007.
   PubMed Web of Science ®Google Scholar
• Ye R, Wang QA, Tao C, Vishvanath L, Shao M, McDonald JG, Gupta RK, Scherer PE. 2015. Impact of tamoxifen on adipocyte lineage tracing: inducer of adipogenesis and prolonged nuclear translocation of Cre recombinase. Mol Metab 4:771–778. https://doi.org/10.1016/j.molmet.2015.08.004.
   PubMed Web of Science ®Google Scholar
• Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, Feng D, Zhuo D, Stoeckert CJ, Jr., Liu XS, Lazar MA. 2008. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22:2941–2952. https://doi.org/10.1101/gad.1709008.
   PubMed Web of Science ®Google Scholar
• Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, Borgesen M, Francoijs KJ, Mandrup S, Stunnenberg HG. 2008. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 22:2953–2967. https://doi.org/10.1101/gad.501108.
   PubMed Web of Science ®Google Scholar
• Sugii S, Olson P, Sears DD, Saberi M, Atkins AR, Barish GD, Hong SH, Castro GL, Yin YQ, Nelson MC, Hsiao G, Greaves DR, Downes M, Yu RT, Olefsky JM, Evans RM. 2009. PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc Natl Acad Sci U S A 106:22504–22509. https://doi.org/10.1073/pnas.0912487106.
   PubMed Web of Science ®Google Scholar
• Soccio RE, Chen ER, Rajapurkar SR, Safabakhsh P, Marinis JM, Dispirito JR, Emmett MJ, Briggs ER, Fang B, Everett LJ, Lim HW, Won KJ, Steger DJ, Wu Y, Civelek M, Voight BF, Lazar MA. 2015. Genetic variation determines PPARgamma function and anti-diabetic drug response in vivo. Cell 162:33–44. https://doi.org/10.1016/j.cell.2015.06.025.
   PubMed Web of Science ®Google Scholar
• Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML. 2003. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278:34268–34276. https://doi.org/10.1074/jbc.M300043200.
   PubMed Web of Science ®Google Scholar
• Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. 2003. Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9:1491–1497. https://doi.org/10.1038/nm956.
   PubMed Web of Science ®Google Scholar
• Wan Y, Chong LW, Evans RM. 2007. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med 13:1496–1503. https://doi.org/10.1038/nm1672.
   PubMed Web of Science ®Google Scholar
• Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY, Watt MJ, Benner C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass CK, Ricote M. 2007. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 117:1658–1669. https://doi.org/10.1172/JCI31561.
   PubMed Web of Science ®Google Scholar
• Chen Z, Vigueira PA, Chambers KT, Hall AM, Mitra MS, Qi N, McDonald WG, Colca JR, Kletzien RF, Finck BN. 2012. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor gamma-sparing thiazolidinedione. J Biol Chem 287:23537–23548. https://doi.org/10.1074/jbc.M112.363960.
   PubMed Web of Science ®Google Scholar
• Colca JR, McDonald WG, Cavey GS, Cole SL, Holewa DD, Brightwell-Conrad AS, Wolfe CL, Wheeler JS, Coulter KR, Kilkuskie PM, Gracheva E, Korshunova Y, Trusgnich M, Karr R, Wiley SE, Divakaruni AS, Murphy AN, Vigueira PA, Finck BN, Kletzien RF. 2013. Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)—relationship to newly identified mitochondrial pyruvate carrier proteins. PLoS One 8:e61551. https://doi.org/10.1371/journal.pone.0061551.
   PubMed Web of Science ®Google Scholar
• Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD. 2005. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med 11:861–866. https://doi.org/10.1038/nm1278.
   PubMed Web of Science ®Google Scholar
• Borsting E, Cheng VP-C, Glass CK, Vallon V, Cunard R. 2012. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney. Am J Physiol Renal Physiol 302:F540–F551. https://doi.org/10.1152/ajprenal.00306.2011.
   PubMed Web of Science ®Google Scholar
• Colca JR, McDonald WG, Waldon DJ, Leone JW, Lull JM, Bannow CA, Lund ET, Mathews WR. 2004. Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe. Am J Physiol Endocrinol Metab 286:E252–E260. https://doi.org/10.1152/ajpendo.00424.2003.
   PubMed Web of Science ®Google Scholar
• Colca JR, VanderLugt JT, Adams WJ, Shashlo A, McDonald WG, Liang J, Zhou R, Orloff DG. 2013. Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer. Clin Pharmacol Ther 93:352–359. https://doi.org/10.1038/clpt.2013.10.
   PubMed Web of Science ®Google Scholar
• Wang QA, Tao C, Jiang L, Shao M, Ye R, Zhu Y, Gordillo R, Ali A, Lian Y, Holland WL, Gupta RK, Scherer PE. 2015. Distinct regulatory mechanisms governing embryonic versus adult adipocyte maturation. Nat Cell Biol 17:1099–1111. https://doi.org/10.1038/ncb3217.
   PubMed Web of Science ®Google Scholar
• Wang QA, Tao C, Gupta RK, Scherer PE. 2013. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 19:1338–1344. https://doi.org/10.1038/nm.3324.
   PubMed Web of Science ®Google Scholar
• Sun K, Wernstedt Asterholm I, Kusminski CM, Bueno AC, Wang ZV, Pollard JW, Brekken RA, Scherer PE. 2012. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci U S A 109:5874–5879. https://doi.org/10.1073/pnas.1200447109.
   PubMed Web of Science ®Google Scholar
• Perl A-KT, Wert SE, Nagy A, Lobe CG, Whitsett JA. 2002. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci USA 99:10482–10487. https://doi.org/10.1073/pnas.152238499.
   PubMed Web of Science ®Google Scholar
• Wang Q, Jiang L, Wang J, Li S, Yu Y, You J, Zeng R, Gao X, Rui L, Li W, Liu Y. 2009. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Hepatology 49:1166–1175. https://doi.org/10.1002/hep.22774.
   PubMed Web of Science ®Google Scholar
• Xia JY, Holland WL, Kusminski CM, Sun K, Sharma AX, Pearson MJ, Sifuentes AJ, McDonald JG, Gordillo R, Scherer PE. 2015. Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis. Cell Metab 22:266–278. https://doi.org/10.1016/j.cmet.2015.06.007.
   PubMed Web of Science ®Google Scholar
• Morley TS, Xia JY, Scherer PE. 2015. Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements. Nat Commun 6:7906. https://doi.org/10.1038/ncomms8906.
   PubMed Web of Science ®Google Scholar
• Ye R, Scherer PE. 2013. Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab 2:133–141. https://doi.org/10.1016/j.molmet.2013.04.001.
   PubMed Web of Science ®Google Scholar
• Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN, Scherer PE. 2005. Fat apoptosis through targeted activation of caspase 8:a new mouse model of inducible and reversible lipoatrophy. Nat Med 11:797–803. https://doi.org/10.1038/nm1262.
   PubMed Web of Science ®Google Scholar
• Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, Reitman ML. 2000. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106:1221–1228. https://doi.org/10.1172/JCI11245.
   PubMed Web of Science ®Google Scholar
• Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–26749. https://doi.org/10.1074/jbc.270.45.26746.
   PubMed Web of Science ®Google Scholar